Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Philips Healthcare

Operates in Diagnostic Imaging Systems, Patient Care and Clinical Informatics, Customer Services, and Home Healthcare... read more Featured Products: More products

Download Mobile App




Use of High-Temperature Superconductors to Make MR Imaging More Affordable, Accessible and Sustainable

By HospiMedica International staff writers
Posted on 07 Dec 2022

A new research partnership focuses on the use of high-temperature superconductors to make MR imaging more affordable, accessible and sustainable in the future. More...

Operating at higher temperatures and eliminating the use of liquid helium during both production and operation could reduce the size, weight and cost of MRI scanners, increasing accessibility across all patient communities and bringing advanced diagnostic imaging closer to a first line diagnostic tool.

Royal Philips (Amsterdam‎, Noord-Holland) has entered into a research partnership with magnet solutions provider MagCorp (Tallahassee, FL, USA) to explore superconducting magnets for MR scanners that do not require cooling to ultra-low temperatures (-452 °F or -269 °C) using liquid helium. Developing more sustainable alternatives to helium-cooled MRI magnets at a lower cost has the potential to offer significant benefits by making advanced MR imaging available to more patients in more diverse settings as well as potentially reducing radiology department capital and operating costs.

Operating at higher temperatures closer to ambient room temperature and eliminating liquid helium from both the production and operation of MRI scanners provides two major advantages. First, it decreases energy consumption required to sustain operation and reduces dependence on a finite and increasingly scarce natural resource, produced largely as a by-product of fossil-fuel (natural gas) extraction. Conventional MRI scanners often vent helium, which once released into the atmosphere escapes into outer space never to be seen again. Second, and just as important, it has the potential to reduce the size, weight and costs of MRI scanners. As a result, MRI’s superior diagnostic and functional imaging capabilities – notably its excellent soft-tissue imaging and absence of ionizing X-ray radiation – could be enjoyed by a larger number of patients, expanding access into underserved communities. The partnership between Philips and MagCorp aims to help realize these two major advantages.

With the introduction of its BlueSeal magnet technology in 2018, Philips already has a commercially available non-venting MRI scanner in widespread use that once charged with a small amount of helium (7 liters instead of a conventional scanner’s 1,500 liters) are sealed and operate without requiring additional helium for their entire operational life. Clinical MRI scanners that completely eliminate the need for helium are a clear direction for innovation in the long term. Using high-temperature superconductors supports a complete shift towards helium independence. The research partnership will focus on characterizing and demonstrating the feasibility of appropriate superconducting materials capable of operating at higher temperatures than today’s niobium-based superconductors. In common with helium, niobium is also a scarce element, whereas some of the new materials being investigated by the research team are based on more abundant elements. In addition to basic materials research, the team will also investigate the steps needed to commercialize the materials, and the technologies needed to enable their use in future MRI scanners.

“Florida State University’s MagLab, part of the U.S. National High Magnetic Field Laboratory, is home to many of the world’s leading researchers on novel superconducting materials that don’t require liquid helium temperatures to operate. Philips has decades of MR scanner design and development experience, including most recently the launch of the BlueSeal magnet technology,” said Josh Hilderbrand, Director, Head of MRI Magnet Research and Development at Philips. “Combining these resources with MagCorp’s research facilitation services will help leverage the latest technology to accelerate access and availability of MRI to more patients and healthcare providers.”

“MagCorp is proud of this partnership, which brings together Philips' game-changing BlueSeal magnet technology and the FSU MagLab’s unrivaled knowledge base about superconductors that can operate in a helium-free environment," said Jeff Whalen, Director of MagCorp. "Combining Philips' forward-thinking approach with FSU MagLab's scientists, who have a wealth of relevant expertise in the application of new superconductors, means Philips will be in the best position to develop innovations around this technology."

Related Links:
Royal Philips
MagCorp


Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Desk Aneroid Sphyg
Diagnostix 750D+
Wound Irrigation Solution
Prontosan®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image Credit: Adobe Stock

Noninvasive Imaging Approach Aims to Detect Basal Cell Carcinoma Before It Becomes Visible

Basal cell carcinoma is the most common form of skin cancer and can damage nearby structures such as the nose or eyes when it develops on the face. Diagnosis typically depends on visible skin changes,... Read more

Surgical Techniques

view channel
Image: Associate Professor Menglin Chen studies how the light-sensitive nanoparticles affect living cells. The screen shows calcium being released inside a cell after nanoparticles taken up by the cell are exposed to blue light. Calcium plays an important role in cellular signaling, and the experiment helps the researchers understand how the nanoparticles can translate light into biological activity. (Photo courtesy of Aarhus University, Johanne Holm Jensen)

Light-Activated Nanoparticles May Offer New Approach to Retinal Prostheses

Retinitis pigmentosa is a degenerative retinal disorder in which photoreceptors progressively die, reducing visual signals to the brain while leaving surviving inner retinal circuits underused.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.